TY  - JOUR
AU  - Spitaleri, Gianluca
AU  - Passaro, Antonio
AU  - Marinis, Filippo de
PY  - 2018
TI  - Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets
JF  - Chinese Clinical Oncology; Vol 8, Supplement 1 (October 22, 2019): Chinese Clinical Oncology
Y2  - 2018
KW  - 
N2  - Around 3–7% of patients with non-small cell lung cancer (NSCLC) have a translocation in the gene for anaplastic lymphoma kinase (ALK) (1). Since the first report of ALK detection in NSCLC in 2007, the prognosis and the treatment landscape has been revolutionized for this setting of patients (2).
UR  - https://cco.amegroups.org/article/view/21819